These aptamers specifically blocked TNF-α-TNFR1 signaling while leaving TNF-α-TNF receptor 2 interactions unaffected, providing a promising avenue for the development of more targeted anti-RA therapies.153. The gene discussed is TNFRSF1A; the disease is rheumatoid arthritis.